Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01751230 · ClinicalTrials.gov registry record · NA

A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women

A NA study of Postpartum Weight Retention, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01751230: Completed NA study of Postpartum Weight Retention, sponsored by Pennington Biomedical Research Center.

NCT01751230 is a NA study of Postpartum Weight Retention that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 40 participants, below the 332-participant average among 7 other Postpartum Weight Retention trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01751230, a NA study of Postpartum Weight Retention, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to help women lose the weight they gained during their pregnancy using a SmartPhone app the investigators have developed called E-Moms. The investigators hypothesize that the moms given the app to use during the study will lose more weight than the moms who do not use the app.

Primary Outcome

The primary outcome measure is weight change after the 16 week intervention.

Interventions

  • BEHAVIORAL WIC E-Moms

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-08
Est. Completion 2014-10
Phase NA

What the finished NCT01751230 record still lists

NCT01751230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 332-participant average among 7 other Postpartum Weight Retention trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Postpartum Weight Retention appearing as the primary indexed condition, and to 1 intervention - of which WIC E-Moms is the first listed.

NCT01751230 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT01751230 about?

NCT01751230 is a clinical study titled "A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women". The purpose of this study is to help women lose the weight they gained during their pregnancy using a SmartPhone app the investigators have developed called E-Moms. The investigators hypothesize that the moms given the app to use during the study will lose more weight than the moms who do not use th...

What is the current status of trial NCT01751230?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-08. Estimated completion is 2014-10.

What conditions does trial NCT01751230 study?

This clinical trial studies the following conditions: Postpartum Weight Retention.

What interventions are being tested in trial NCT01751230?

The interventions under investigation include: WIC E-Moms (BEHAVIORAL).

Who is sponsoring clinical trial NCT01751230?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01751230 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Weight Retention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01751230, the US trial registry maintained by the National Library of Medicine. NCT01751230 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.